Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studiesDavid Broadhurst, Warwick B. Dunn|Metabolomics|2018Cited by 838
Metabolomics enables precision medicine: “A White Paper, Community Perspective”Rima Kaddurah‐Daouk, Lorraine Brennan, David S. Wishart et al.|Metabolomics|2016Cited by 615
Towards quality assurance and quality control in untargeted metabolomics studiesRichard D. Beger, Krista A. Zanetti, Warwick B. Dunn et al.|Metabolomics|2019Cited by 149
Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC–MS based untargeted metabolomics practitionersAnne M. Evans, Dajana Vuckovic, Claire O’Donovan et al.|Metabolomics|2020Cited by 117